Patients with coronary artery disease should receive P2Y12 inhibitor instead of aspirin
P2Y12 inhibitor monotherapy lowers the risk of ischemic events compared with aspirin alone in patients with coronary artery disease without increasing bleeding risk, according to late breaking research presented in a Hot ...
Aug 29, 2022
0
7